Search
for
Sort by
Research 751–780 of 1000+
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Serial Hydrolysis for the Simultaneous Analysis of Catecholamines and Steroids in the Urine of Patients with Alopecia Areata
- Lupus erythematosus: systemic and cutaneous manifestations
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Case 21-2012
- Inhibition of Established Tuberculin Hypersensitivity by Methptrexate,
- Two mouse mutations mapped to chromosome 11 with differing morphologies but similar progressive inflammatory alopecia
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Selected topics in pediatric hair loss
- Hair and scalp disorders
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- ANTI-INFLAMMATORY ACTIVITY OF PLATELET-RICH PLASMA TREATMENT IN THE INFLAMMATION MANAGEMENT OF KNEE OSTEOARTHRITIS: EXPERIMENTAL STUDY
- Contents
- Central hair loss in African American women: Incidence and potential risk factors
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- M2 Macrophage and Extracellular Matrix Genes Are Enriched in High‐Activity Lichen Planopilaris
- Scalp Itch: A Systematic Review
- Extraskeletal actions of vitamin D
- Treatment options for alopecia: an update, looking to the future
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Aldesleukin
- Conjoint analysis of methylation, transcriptomic, and proteomic profiles in pemphigus vulgaris
- 229 Single cell transcriptomics identifies a potential role for Arg1+ macrophages in alopecia areata pathogenesis
- 397 Predictive modeling of drug response and mechanism of action in alopecia areata clinical trials
- Esssentials of Systemic Lupus Erythematosus
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Oral Lichen Planus
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Gut microbiome, metabolome and alopecia areata